Top Markets
Coin of the day
BG Medicine, Inc. BG Medicine, Inc.

BG Medicine, Inc.

BGMD
Rank in Stocks #42481
BG Medicine, Inc. is dedicated to the development and commercialization of... BG Medicine, Inc. is dedicated to the development and commercialization of diagnostic products aimed at guiding patient care for individuals in the United States afflicted with heart failure and related conditions. Its product portfolio includes the BGM Galectin-3 Test, an in vitro diagnostic solution that quantifies galectin-3 levels in blood serum or plasma using an enzyme-linked immunosorbent assay (ELISA) on a microtiter plate platform. Additionally, the company provides the CardioSCORE Test, a multi-analyte, biomarker-based blood test designed to assess the short-term risk of atherothrombotic cardiovascular events, such as myocardial infarction (heart attack) and ischemic stroke. BG Medicine maintains licensing, development, and commercialization agreements with major partners like Abbott Laboratories, bioMΓ©rieux SA, Siemens Healthcare Diagnostics Inc., and Alere Inc., specifically for automated versions of its galectin-3 test. Furthermore, it has forged a strategic alliance with Abbott Laboratories to jointly develop and market galectin-3 assay kits, along with their corresponding control kits and calibrators. Founded in 2000, the company was initially known as Beyond Genomics, Inc., before rebranding to BG Medicine, Inc. in October 2004. Its corporate headquarters are located in Waltham, Massachusetts.
Share Price
$0.0001
Last synced: 2026-08-11
Market Cap
$1.14K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade BG Medicine, Inc. (BGMD)

Category

Stock price history for BG Medicine, Inc. (BGMD)
Highest end of day price: $0.00 on 2026-08-01

Lowest end of day price: $33.28 on 2011-02-01
Stock price history of BG Medicine, Inc. from 2011 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 0.00%
2025 -9.46%
2024 -9.43%
2023 -69.12%
2022 223.81%
2021 -99.74%
2020 287.26%
2019 -54.23%
2018 -48.32%
2017 -33.28%
2016 -88.44%
2015 -62.26%
2014 -60.09%
2013 -60.12%
2012 -46.91%
2011 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$401.71 -16.72%
US
$195.00 -36.40%
FR
$172.02 27.75%
JP
$183.17 18.89%
US
$77.02 -11.48%
CH